The hormonal composition of follicular fluid and its implications for ovarian cancer pathogenesis

被引:50
作者
Emori, Megan M. [1 ]
Drapkin, Ronny [1 ]
机构
[1] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
Follicular fluid; Ovarian cancer; Hormones; ANTI-MULLERIAN HORMONE; STIMULATING-HORMONE; LUTEINIZING-HORMONE; FALLOPIAN-TUBE; BREAST-CANCER; SIGNALING PATHWAY; MLLERIAN HORMONE; MOUSE OVARY; CELLS; FOLLICLES;
D O I
10.1186/1477-7827-12-60
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ovulation has long been associated with an increased risk in ovarian cancer, yet the underlying molecular mechanisms remain obscure. Two aspects of ovulation have been linked to ovarian cancer pathogenesis. The first is the impact of repetitive tissue injury and repair that occurs with each ovulatory event. The second is the release of follicular fluid that accompanies the follicular rupture and its effect on the ovarian and fallopian tube epithelial cells. Hormones are an important component of follicular fluid, which transiently bathes the ovarian surface and fallopian tube epithelium during ovulation. Much work has been done exploring the role of hormones in fertility, but some, such as estrogen, have also been implicated in the pathogenesis of ovarian and other cancers. Understanding the role of hormones within follicular fluid, as well as how they are altered in disorders which increase ovarian cancer risk, will enhance our ability to assess risk and develop preventative strategies. This review provides an in depth discussion of the logistics of using and studying follicular fluid in ovarian cancer research, and discusses the fluctuations in follicular fluid hormone levels during normal physiological processes versus conditions that increase ovarian cancer risk.
引用
收藏
页数:8
相关论文
共 75 条
[51]  
Lyon MF, 1979, P ROY SOC LOND B BIO, V208, P1
[52]   Targeted disruption of luteinizing hormone β-subunit leads to hypogonadism, defects in gonadal steroidogenesis, and infertility [J].
Ma, XP ;
Dong, YL ;
Matzuk, MM ;
Kumar, TR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (49) :17294-17299
[53]  
Mak VCY, 2012, HISTOL HISTOPATHOL, V27, P1121, DOI 10.14670/HH-27.1121
[54]   Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management [J].
Mandai, Masaki ;
Yamaguchi, Ken ;
Matsumura, Noriomi ;
Baba, Tsukasa ;
Konishi, Ikuo .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (05) :383-391
[55]   Shorter telomere length is associated with increased ovarian cancer risk in both familial and sporadic cases [J].
Martinez-Delgado, Beatriz ;
Yanowsky, Kira ;
Inglada-Perez, Lucia ;
de la Hoya, Miguel ;
Caldes, Trinidad ;
Vega, Ana ;
Blanco, Ana ;
Martin, Teresa ;
Gonzalez-Sarmiento, Rogelio ;
Blasco, Maria ;
Robledo, Mercedes ;
Urioste, Miguel ;
Song, Honglin ;
Pharoah, Paul ;
Benitez, Javier .
JOURNAL OF MEDICAL GENETICS, 2012, 49 (05) :341-344
[56]   Regulation of gonadotropin secretion: Implications for polycystic ovary syndrome [J].
McCartney, CR ;
Eagleson, CA ;
Marshall, JC .
SEMINARS IN REPRODUCTIVE MEDICINE, 2002, 20 (04) :317-325
[57]  
Murakami J, 1997, CANCER, V80, P1085
[58]   Women with reduced ovarian reserve or advanced maternal age have an altered follicular environment [J].
Pacella, Leanne ;
Zander-Fox, Deirdre L. ;
Armstrong, David T. ;
Lane, Michelle .
FERTILITY AND STERILITY, 2012, 98 (04) :986-+
[59]   Formation of the Ovarian Follicular Antrum and Follicular Fluid [J].
Rodgers, Raymond J. ;
Irving-Rodgers, Helen F. .
BIOLOGY OF REPRODUCTION, 2010, 82 (06) :1021-1029
[60]  
Shalgi R, 1973, FERTIL STERIL, V48, P109